@article{QIMS27779,
author = {Hana Malikova},
title = {Nephrogenic systemic fibrosis: the end of the story?},
journal = {Quantitative Imaging in Medicine and Surgery},
volume = {9},
number = {8},
year = {2019},
keywords = {},
abstract = {Gadolinium-based contrast agents (GBCA) have been standardly intravenously applied to improve visibility of MRI examinations since 1988, when gadopentetate dimeglumine (Magnevist®) was approved for clinical practice. Gadolinium itself is a heavy metal, highly toxic in biological systems. Therefore, gadolinium must be bound to ligands for the purpose of contrast agents.},
issn = {2223-4306}, url = {https://qims.amegroups.org/article/view/27779}
}